Product record
Vrizarox Dt Cefpodoxime Proxetil: batches declared Not of Standard Quality
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026
1 batch of products named "Vrizarox Dt Cefpodoxime Proxetil" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between October 2024 and October 2024. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
1 record linked to Vrizarox Dt Cefpodoxime Proxetil in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| CABQ4001Mfg 2024-01 · Exp 2025-12 | Chiros PharmaHimachal Pradesh | MISBRANDED The monograph of Cefpodoxime Tablets in the current edition of Indian Pharamacopoeia i.e. IP-2022. is also applicable for Cefpodoxime Dispersible Tablets as indicated under labelling section of the monograph. However the firm failed to indicate the latters IP after the product name CefpodoximeDispersible Tablets. Hence, the drug is deemed to be Misbranded as per section 17 of the Drugs and Cosmetics Act, 1940, since it is not labeled in the prescribed mannar.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab | Oct 2024 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.